logo

1.86

1.86 (0.02%)

As of Mar 06, 2024

Auris Medical Holding Ltd. [CYTO]

Source: 

Company Overview

We are a clinical-and commercial-stage biopharmaceutical company developing therapeutics that address important unmet medical needs. We are currently active in two areas: the development of RNA delivery technology and therapeutics for extrahepatic targets (OligoPhore™ / SemaPhore™ platforms; AM-401 for the treatment of KRAS driven cancer, AM-411 for the treatment of rheumatoid arthritis; preclinical), and nasal sprays for protection against airborne allergens, and where approved, viruses (Bentrio  ; commercial) or the treatment of vertigo (AM-125; Phase 2).

CountryUnited States
Headquartershamilton hm 11
Phone Number41 (0) 41 729 71 94
Industry
manufacturing
CEOThomas Meyer
Websitealtamiratherapeutics.com

Related Stories